138 However, as argued by the appellant, the General Court erred in rejecting the existence of a link between those expenses, in particular as regards the costs incurred in connection with the action against the prohibition decision of 23 September 1997 and the fact that the Commission did not adopt a decision on the basis of Article 8(2) of Directive 93/42 in relation to the Inhaler device.
138 Međutim, kao što to ističe žalitelj, Opći sud nije mogao odbaciti postojanje veze između tih troškova, posebno u pogledu troškova nastalih u okviru postupka prigovora pokrenutog protiv odluke o zabrani od 23. rujna 1997., i činjenice da Komisija nije donijela odluku na temelju članka 8. stavka 2. Direktive 93/42 u pogledu proizvoda Inhaler.Eurlex2018q4 Eurlex2018q4